Pharmacokinetics of ethylene in man by on-line laser photoacoustic detection by Berkelmans, H.W.A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/100933
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Pharmacokinetics of Ethylene in Man by
On-line Laser Photoacoustic Detection
H.W.A. Berkelmans b B.W.M. Moeskops b J. Bominaar b
P.T.J. Scheepers a F.J.M. Harren b,1
aDepartment of Epidemiology and Biostatistics, UMC St Radboud, Nijmegen, The
Netherlands
bDepartment of Molecular and Laser Physics, University of Nijmegen, Nijmegen,
The Netherlands
adress for manuscript correspondence: Bas Moeskops
basmoesk@sci.kun.nl
Fax: (+31)-24-3653311
Telephone (+31)-24-3653029
1 To whom correspondence should be addressed at Department of Molecular and
Laser Physics, University of Nijmegen, P.O. Box 9010, NL-6500 GL Nijmegen, The
Netherlands.
Preprint submitted to Elsevier Science 24 February 2003
Pharmacokinetics of Ethylene in Man by On-line Laser Photoacoustic
Detection. H.W.A. Berkelmans, B.W.M. Moeskops, J. Bominaar, P.T.J.
Scheepers, F.J.M. HarrenToxicol. Appl. Pharmacol.
Abstract
The pharmacokinetics of ethylene are determined using laser based photoacoustic
detection and a closed chamber setup. Concentration-time data are analyzed using
a two-compartment and a physiologically based pharmacokinetic (PBPK) model.
Endogenous production was 92 ± 13 pmol· h−1kg−1 for the two-compartment model
and 75 ± 10 pmol·h−1·kg−1 for the PBPK model. These values agree with previous
work at our department, but are significantly lower than published values based
on gas chromatography. The blood:air partition coefficient in the PBPK model was
determined by curve fitting, because simulations based on published values did not
agree well with data. Curve fitting gave a value of 0.092 ± 0.029. The real-time
nature and high sensitivity of photoacoustic detection make it a useful addition to
gas chromatography in closed chamber studies.
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Introduction
Trace gas analysis of the composition of exhaled air gives information about a
wide variety of processes occurring inside the human body. One such process
is free-radical mediated lipid peroxidation. In lipid peroxidation, polyunsatu-
rated fatty acids react with reactive oxygen species to form a variety of prod-
ucts, including pentane, ethane and ethylene (ET) (Esterbauer, 1996; Harren
et al., 1999). In this study ET will be measured as a marker for this process.
However, ET is not only produced during lipid peroxidation. Other suggested
sources of endogenous ET are the oxidation of free methionine (Lieberman
et al., 1964; Kessler and Remmer, 1990), oxidation of hemoglobin (Kessler,
1987) and metabolism of intestinal bacteria (Gelmont et al., 1981; To¨rnqvist
et al., 1989). It was shown that ET produced by oxidation of methionine forms
a minor and negligible contribution to total ET production (Kneepkens et al.,
1994).
A previous study from our department suggested that the use of ET as a fast,
non-invasive and on-line biomarker of lipid peroxidation is possible (Harren
et al., 1999). Knowledge of the pharmacokinetic parameters of ET in healthy
human subjects is a prerequisite to useful applications in humans. Studies
of the pharmacokinetics of ethylene in man have been published previously
(Csana´dy et al., 2000). Often pharmacokinetic parameters are determined
from gas uptake studies, which conventionally use a closed chamber technique
(Filser, 1992) combined with gas chromatography. This technique requires con-
centration of the hydrocarbons on a solid sorbent. The choice of the proper
sorbent material during the concentration step is critical. Permeability of and
adsorption to the wall of the sample container, and possible contamination
with ambient air may cause artefacts which make breath samples uninter-
pretable. To overcome this delicate and time consuming concentration step
we propose to use a laser based trace gas detection technique, which has such
a high sensitivity for ET that accumulation is no longer needed, and online
measurements become possible.
The goal of this study is to determine the pharmacokinetics of ET with this
laser based detection and a closed chamber setup. From the data the parame-
ters of both a two-compartment and a physiologically based pharmacokinetic
(PBPK) model are determined.
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Methods
Exposure system
To investigate the pharmacokinetics of ET, a closed breath circuit was used
(Fig.1). This circuit consists of 2 glass pots containing CO2-absorbing sodalime
r,
a 2 L. balloon, an O2-inlet, pressure valves and a mouthpiece. The O2−concentration
was monitored by an infrared gas analyser (URAS 14, ABB, Zurich, Switzer-
land) and kept at 21 ± 1 % vol by addition of 100 % O2 using a 25L·h
−1 mass
flow controller (5850S, Brooks Instrument, Veenendaal, The Netherlands). The
closed breath circuit was connected to the detection system, the URAS 14
and the O2-bottle as shown in Fig. 1. The flow through the detection cell
was kept at 3.00 ± 0.01 L·h−1 by a membrane pump combined with a mass
flow controller (5850S, Brooks Instrument). All flow rates were measured and
controlled by a Read Out & Control Interface (0154, Brooks Instrument).
Real-time monitoring of ethylene
The ET concentration was monitored in real time by using a sensitive laser-
based photoacoustic detector. A schematic diagram of the setup is given in
Fig. 1. Briefly, the detector consists of a line-tunable CO2-laser emitting ra-
diation in the 9 to 11 µm region and a photoacoustic cell, in which the gas
is detected. The requirements for gases to be detected with this detector is
that they posses a high absorption strength and a characteristic absorption
pattern in the wavelength range of the CO2-laser. Inside the photoacoustic cell
traces of ET can absorb the laser radiation; the absorbed energy is released
into heat, which creates an increase in pressure inside a closed volume. By
modulating the laser beam with a mechanical chopper, pressure waves (i.e.,
sound) are generated and detected with a sensitive miniature microphone.
The laser-based photoacoustic detector is able to distinguish between differ-
ent gases by making use of their wavelength-dependent fingerpint absorption
characteristics. ET gas mixtures are sensitively measured by the laser-based
photoacoustic detector due to the distinct fingerprint-like spectrum of ET in
the CO2-laser wavelength range. By comparing the photoacoustic signals on
various laser lines (at which ET has different absorption strenghts) the re-
sponse of ET can be distinguished from interfering background signals that
do not show such an absorption spectrum. The CO2-laser is alternately tuned
to the 10P14 (λ = 948.48 cm−1) and 10P12 (λ = 951.19 cm−1) laser lines, and
at each line the photoacoustic signal is recorded. The absorption coefficients
of ET at these wavelengths (see Fig. 2) add specificity to the calculation of
the ET concentration. In addition, several measures were taken to prevent
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interfering gases from entering the detection cell in the first place. A sodal-
ime scrubber and a KOH scrubber were used to remove CO2 from the sample
air. A CaCl2 scrubber was used to decrease the water content of the sample
gas. Volatile gases were removed using a liquid nitrogen cooled cryogenic trap
(125 K). The amplitude of the acoustic waves is directly proportional to the
concentration of ET in the photoacoustic cell (Harren and Reuss, 1997). The
length of the detection cell and the frequency of modulation of the laser are
matched, so that the generated sound resonates inside the detection cell. This
resonance-effect significantly increases sensitivity. The photoacoustic cell con-
sists of a straight tube, with a small microphone embedded in the middle, a
gas inlet, and a gas outlet. The small volume of the detection cell allows a
fast response because the sample is not diluted when flowing through the cell.
This system has a detection limit for ethylene of 6 ppt. (Harren and Reuss,
1997). Fig. 3 shows the time response of the detection system.
Laser based photoacoustic detectors are able to monitor trace gas concentra-
tions under atmospheric conditions with orders of magnitude better sensitivity
than most gas chromatography instrumentation. In addition, they are able to
monitor non-invasively and on-line under dynamic conditions (Harren et al.,
2000). The photoacoustic instrument used in this study has been developed at
the University of Nijmegen specifically for biological applications, in particu-
lar for monitoring the production of ethylene by plants (Bijnen et al., 1996;
Voesenek et al., 1990).
Subjects
All volunteers were males between the ages of 20 and 53 years, see also Tab.
1. None of the subjects indicated to have any chronic illnesses, and all were
non-smokers. ET levels were measured at rest. The experiments were carried
in accordance with the guidelines stated in the ’World Medical Association
Declaration of Helsinki-Ethical Principles for Medical Research Involving Hu-
man Subjects’ (52nd WMA General Assembly, 2000) and the ’Convention for
the Protection of Human Rights and Dignity of the Human Being with regard
to the Application of Biology and Medicine: Convention on Human Rights
and Biomedicine’ (Convention on Human Rights and Biomedicine, 1997) .
Experiments
Two types of pharmacokinetic experiments were performed. In both, a vol-
unteer breathed from the closed circuit for approximately one hour. In the
first type of experiment, a small amount of pure ET (Air Liquide, Eindhoven,
The Netherlands) was injected into the system using a syringe, and the de-
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cline of the high initial concentration was monitored. Eleven measurements
on 4 subjects were performed in this way, with initial concentrations vary-
ing from 0.1-5 ppm (Tab. 1). These measurements allowed examining of the
partitioning of ET between body and air. In the second type of experiments
the system was flushed with compressed air prior to connecting the volun-
teer. In this way, a low (<5 ppb) initial concentration was achieved. Eighteen
experiments with low initial concentration were performed on 9 subjects in
this manner (Tab. 1). These measurements were used to quantitate the en-
dogenous production of ET. In addition to these experiments, we used for
our model other experimental data from UV light experiments (Harren et al.,
1999). The concentration-time curves of all experiments were simulated using
the two pharmacokinetic models.
Analysis
The two-compartment model
The two-compartment model used here was taken from literature (Filser,
1992). It assumes the whole body of the organism to function as one well-mixed
compartment. A schematic representation of the two-compartment model is
given in Fig. 4. The model is described by the two differential equations shown
in Eq. 1 and Eq. 2. Here, V1 represents the volume of the closed breath circuit
(including lung volume), and V2 represents the volume of the body of the vol-
unteer. y1(t) and y2(t) represent the ET-concentration in the closed chamber
and the body of the subject, respectively. Both compartments are separated
by a boundary layer representing the alveolar surface. The exchange of gases
through this boundary layer is a first-order process where k12 and k21 are the
exchange constants ([h−1]). The elimination of ET from the body is described
by the the metabolic rate constant kel ([h
−1]). Production of ET by the body
is described by the rate of endogenous production dNpr/dt ([nmol·h
−1]).
V1
dy1(t)
dt
= V2k21y2(t)− V1k12y1(t) (1)
V2
dy2(t)
dt
= V1k12y1(t)− V2(k21 + kel)y2(t) +
dNpr
dt
(2)
Analysis of the closed chamber measurements starts with fitting a double-
exponential to data from experiments with a high initial concentration (Denk,
1990), see Eq. 3. The curve parameters λ1,λ2, C1 and C2 determine the ex-
change rate constants k12 and k21 and the metabolic rate constant kel, as
shown in Eq. 4, 5 and 6. C3 represents a plateau concentration where en-
dogenous production and metabolic clearance are in equilibrium. The value
of C3 was set to zero in fitting the double-exponential to the data, because
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the effect of endogenous production of ET was considered negligible at high
concentrations. After k12, k21 and kel have been determined, dNpr/dt can be
obtained by applying a numerical fit to data from measurements with low
initial concentration. The body burden of EO due to endogenous production
of ET (yEO2 ) is determined according to Eq. 7. In Eq. 7 the sum of k
EO
el and
kEO21 was taken from literature (Denk, 1990) and equals 0.999. F represents
the fraction of ET that is metabolised to EO and was set to 1 (Denk, 1990).
Results for yEO2 therefore represent a worst case scenario. In previous studies
(Denk, 1990), yEO2 has been used to asses the risk of cancer resulting from
endogenous ET. Such a risk assessment is beyond the scope of this study.
Examples of experimental concentration-time curves and corresponding curve
fits are given in Fig. 5.
y1 = C1 exp λ1t+ C2 exp λ2t+ C3 (3)
kel = −
λ1λ2 (C1 + C2)
(C1λ1 + C2λ2)
(4)
k12 =
λ1λ2
kel
(5)
k21 = − (λ1 + λ2 + kel + k12) (6)
yEO2 (t) =
kely2(t)
F (kEOel + k
EO
21 )
(7)
In addition to the data from closed chamber measurements, concentration-
time curves were also taken from a previous study (Harren et al., 1999). There,
ultraviolet light (UV) was used to induce lipid peroxidation in the skin of hu-
man volunteers (UV-measurements). The ET-concentration in exhaled air was
measured real-time using a single pass setup. In a single pass experiment, the
volunteer inhales from a buffer bag filled with synthetic air containing a low,
constant concentration of ET. A small amount of exhaled air is sampled, while
contamination with ambient air is minimized. To simulate single pass measure-
ments with the two-compartment model it has to be adjusted so that it deals
with inhaling from a low concentration, exhaling into open air, and increased
ET production due to irradiation with ultraviolet light. These adjustments are
shown in Eq. 8 and 9. In Eq. 8, the breath volume (BV) signifies the amount
of air exhaled in litres per hour. To simulate increased ET production in the
skin, a new production term dNUVpr /dt was placed in the compartment repre-
senting the body. The value of dNUVpr /dt was determined by fitting simulated
concentration-time curves to the data.
ySP1 (t) =
V2k21y2(t)
BV
(8)
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V2
dySP2 (t)
dt
= −V2(k21 + kel)y2(t) +
dNpr
dt
+
dNuvpr
dt
(9)
The PBPK model
The PBPK model used here is an adaptation of an earlier model (Csana´dy
et al., 2000) that links the pharmacokinetics of ET and EO. Compartments
related only to EO were omitted. The PBPK model separates the body into
a series of biologically and anatomically relevant compartments. All compart-
ments are then connected in anatomical order, based on the blood circulatory
system. The model describes uptake via inhalation, endogenous production
and metabolism of ET. The model structure is displayed in Fig. 4. Metabolic
clearance (Cl), cardiac output (Qcar), lung volume and alveolar ventilation
(Aalv) were assumed to scale linearly with body surface (Johanson and Filser,
1996), estimated from the volunteers height and weight (Mosteller, 1987). A
mathematical description of the model and the physiological parameters used
therein can be found elsewhere (Csana´dy et al., 2000).
Also this model has been adjusted to deal with single pass UV-measurements.
When simulating these measurements, the ET-concentrations in exhaled air
(CSPexh) and lung blood (C
SP
pb ) are given by equations 10 and 11. When simulat-
ing UV-measurements, the equations describing the vessel rich group and the
venous blood now contain a term reflecting production of ET resulting from
exposure to UV, see Eq. 12 and 13 .
Cspexh =
(Cven − Cpb) ·Qcar
BV
(10)
Vpb
dCsppb
dt
= −Aalv
Cpb
λb
+Qcar (Cven − Cpb) (11)
Vvrg
dCvrg
dt
= Qvrg
(
Cart −
Cvrg
λvrg:b
)
+ P ·
dNuvpr
dt
(12)
Vven
dCven
dt
=
∑
i
CiQi
λi
−QcarCven + (1− P ) ·
dNuvpr
dt
(13)
Results
Two-compartment model
Figure 5 shows three of the measurements with high initial concentration
and corresponding curve fits that were used for determining the exchange
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constants k12, k21 and the elimination constant kel. Figure 5 also shows three
of the measurements with low initial concentration and corresponding curve
fits. Pharmacokinetic constants and parameters obtained from the curve fits
are given in table 2. Published values (Denk, 1990) for kEOel and k
EO
21 were used
to calculate the body burden of EO, resulting from endogenous ET. This gave
Y EO2 = 41.8 ± 5.68 pmol·kg
−1.
PBPK model
Attempts were made to fit our data using published values for all model pa-
rameters. Simulations did not agree well with data when published values for
the blood:air partition coefficient (λb:a) were used, e.g. 0.15 (Steward et al.,
1973) and 0.22 (Csana´dy et al., 2000) for λb:a were used. Therefore, λb:a was
fitted to measurements with high initial concentration, resulting in λb:a 0.092
± 0.029. An example is given in Fig. 6. λb:a was fixed at this value during fitting
of the endogenous production to measurements with low initial concentration.
This resulted in dNpr/dt = 75 ± 10 pmol·h
−1
·kg−1.
UV-measurements (Harren et al., 1999) were simulated by temporarily increas-
ing the endogenous production. Overall, optimal agreement with experimental
data was obtained when 60% of the UV-induced ET-production was located
in the venous blood, and 40% in the compartment representing the vessel-rich
group.
Discussion
Two-compartment model
The metabolic rate constant in the two-compartment model kel = 1.24 ±
0.02 h−1 was significantly higher than published earlier, 0.39 h−1 (Denk, 1990).
The body burden of EO resulting from endogenous production is significantly
lower than previously published (Denk, 1990). When calculating the body
burden upon exposure to 1 ppm, our results lead to a 10 % greater body
burden of EO than published results (Filser et al., 1992).
When using the model parameters obtained in this study, simulations of UV-
measurements show little agreement with experimental data. This may be due
to localization of the UV-induced lipid peroxidation near the richly perfused
skin, and the resulting rapid transport to lung tissue. This would mean that
a substantial part of the body is bypassed in the ethylene transport, which
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would explain why the whole-body approach fails to simulate the observed
concentration-time curves.
PBPK model
No clear optimum for the metabolic clearance value Cl in the PBPK model
resulted from fitting sessions, because of the adjustment of the blood:air par-
tition coefficient that was required. Use of a previously published value for Cl
(Csana´dy et al., 2000) gave good agreement between simulation and measure-
ment.
The PBPK model contains numerous parameters. Some of these parameters
are usually determined by curve fitting, namely dNpr/dt and Cl. Other pa-
rameters such as partition coefficients are known from in vitro studies and
should only be determined by curve fitting as a last resort. Parameters that
are independent of the chemical, such as cardiac output and alveolar ventila-
tion were never determined by curve fitting. Following these criteria, efforts
were made to simulate experimental data while varying only dNpr/dt and Cl.
No satisfactory agreement between data and simulations could be found in
this manner. It was observed that published values of the blood:air parti-
tion coefficient (0.15 (Filser et al., 1992), 0.22 (Csana´dy et al., 2000)) did not
give good agreement between simulation and experiment. The variation in
published values and its great impact on simulations suggested adjusting the
blood:air partition coefficient. The value for the blood:air partition coefficient
(0.092) was obtained by numerical curve fitting. Similar simulations could be
obtained by changing the fraction f of inhaled ET that reaches the alveoli
from 1.00 to 0.21. Adjusting the blood-air partition coefficient was considered
the more plausible solution. An f smaller than 1 for ET has been reported in
rats, and was ascribed to the relatively large size of mucus membranes in the
respiratory tract of the rat (Johanson and Filser, 1992).
The best way to include a UV-related production term would be to create a
skin compartment and include the production term there. To do this, several
physiological parameters have to be known. In the case of skin, the skin-air
or skin-blood partition coefficient could not be found in literature. Also, the
rate at which ET permeates through the skin could not be found. To avoid
including a skin compartment, UV-related ET production was placed in two
existing compartments. Part of the ET production was included in the vessel-
rich group compartment, to represent ET production in richly perfused skin
tissue. The rest of the UV-related ET production was placed in the venous
blood, to represent ET production in the blood vessels exiting the skin. The
fraction of the UV-related production located in each compartment can be
adjusted by changing the variable P .
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In conclusion, endogenous production values agree well between the two-
compartment and the PBPKmodel, and with previous work at our department
(Harren et al., 1999). However, endogenous production from both models is
significantly lower than published values based on gas chromatography. Gas
chromatography requires accumulation of the gas sample and concentration of
the analyte on an adsorbing agent. These steps are not necessary with online
photoacoustic detection. Also, in this work measurements lasted one hour,
instead of two hours in previous studies. This shorter measurement time is
compensated by the larger number of datapoints available for curve fits and
the higher sensitivity of laser based detection.
It has been shown that laser photoacoustic detection can be used in combi-
nation with the closed chamber technique to study the pharmacokinetics of
ethylene, as an alternative to gas chromatography. Other endogenous com-
pounds can also be studied using laser photoacoustic detection, where the
sensitivity depends on the characteristics of the lightsource and the absorp-
tion spectrum of the compound. The real-time nature and high sensitivity of
photoacoustic detection allows investigation of dynamical processes on a short
timescale and at low concentrations. It is therefore believed that laser photoa-
coustic detection can be used with the closed chamber technique as a useful
addition to conventional detection schemes.
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Fig. 1. Experimental setup. The closed gas circuit is formed by: 1) volunteer, 2)
sodalime pots, 3) buffer balloon, 4) pressurized O2 bottle, 5) mass flow controller, 6)
membrane pumps, 7) URAS 14, 8) sodalime scrubber 9)KOH scrubber, 10) CaCl2
scrubber, 11) flow controller, 12) cryogenic trap, and C) ET detection cell. The
CO2-laser (D) wavelength is determined by the angle of the grating (E). The chopper
(F) modulates the laser at the resonance frequency of the photoacoustic detection
cell (C), where a microphone records the ethylene signal. A small fraction of the
laser light is transmitted by a mirror (B) and quantified using a powermeter (A).
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Fig. 2. Absorption coefficients of ethylene at the CO2-laser lines
.
Initial Age[y] Height[cm] Weight[kg] N
concentration
Low 27.8 ± 10.5 188 ± 5 81.8 ± 6.2 9
High 23.5 ± 3.8 189 ± 3 82.0 ± 3.8 4
Table 1
Volunteers. All values are given in mean + SD
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Fig. 3. Time response of the photoacoustic detection system. The detection system
was connected to a flow of purified air until t=3.3 min, when a 3.00 ± 0.01 flow of
0.99 ± 0.01 ppm ethylene was connected. The system was reconnected to purified
air at t=10.4 min. The doubling time was 12.5 ± 1.7 sec, and the half life was 13.2
± 0.9 sec.
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Fig. 5. Metabolism and endogenous production of ET in humans. (A) and (B) Con-
centration-time courses of ET in the atmosphere of a closed breath circuit, with
initial concentrations between 1 and 5 ppm. Only 1 out of 5 datapoints is plot-
ted (symbols). The solid lines represent model simulations of the two-compartment
model (A), and the PBPK model (B) In (B), the blood:air partition coefficient was
equal to 0.092 in all simulations. (C) and (D) Concentration-time courses of ET in
the closed breath circuit from measurements with low initial concentration. Only
1 out of 5 datapoints is plotted (symbols). The solid lines represent simulations of
the two-compartment model (C) and PBPK model (D). (E) and (F) Concentra-
tion-time courses of ET in exhaled air during exposure to ultraviolet light. Only 1
out of 2 datapoints is plotted (symbols). The solid lines respresent simulations of
the two-compartment model (E) and PBPK model (F).
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Fig. 6. PBPK model fit to measurement with high initial concentration (4) with
published values for λb:a (dotted line:0.22, dashed line:0.15) and the numerically fit
value λb:a = 0.092 (solid line) . Only one out of 5 datapoints is plotted.
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Constant Expression Value (mean ± SD) Dimension
Clearance of uptake k12 · V1 20.2 ± 2.0 l·h
−1
Rate constant of exhalation k21 1.49 ± 0.09 h
−1
Rate constant of metabolism kel 1.24 ± 0.02 h
−1
Endogenous production rate
dNpr
dt
92 ± 13 pmol· h−1kg−1
Parameter Expression Value (mean ± SD) Dimension
Thermodynamic equilibrium k12V1
k21V2
0.19 ± 0.02 -
coefficient ’body/air’(Keq)
Bodyaccumulation factor k12V1(k21+kel)V2 0.11 ± 0.01 -
’body/air’ at steady state (Kst)
Clearance of exhalation k21V2Kst 11.5 ± 1.3 l·h
−1
Clearance of metabolism kelV2 86.8 ± 1.1 l·h
−1
Half-life in organism ln2(kel+k21) 0.25 ± 0.02 h
% metabolised 100·kel(kel+k21) 45 ± 1 %
% exhaled 100·k21(kel+k21 55 ± 5 %
Body burden of ET due to
dNpr
dt
[(kel+k21)V2]
0.048 ± 0.007 pmol·ml−1 tissue
endogenous production of ET
Table 2
Pharmacokinetic constants of ethylene in man (70 kg). Results are based on eleven
measurements on four volunteers. An average value for each volunteer was first
obtained, then the final average was calculated.
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